Lexapro Pediatric Depression Filing Planned In 2008

Forest and H. Lundbeck announced Phase III study results of the SSRI in adolescents aged 12 to 17.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet